|
Re: Reminder: Resverlogix to Hold Conference Call and Webcast on December 6th, 2019
|
4
|
Resverlogix Corp.
|
Dec 05, 2019 08:48PM
|
|
Re: Reminder: Resverlogix to Hold Conference Call and Webcast on December 6th, 2019
|
3
|
Resverlogix Corp.
|
Dec 05, 2019 08:58PM
|
|
Re: Resverlogix Announces Annual and Special Meeting of Shareholders
|
1
|
Resverlogix Corp.
|
Aug 22, 2019 09:00PM
|
|
Re: Resverlogix Announces Apabetalone Prior to SARS-CoV-2 (COVID-19) Exposure Reduces Viral Infection – Confirms Plans for COVID-19 Clinical Trial
|
9
|
Resverlogix Corp.
|
Dec 22, 2020 08:06AM
|
|
Re: Resverlogix Announces BETonMACE Trial Results Accepted for Presentation at American Heart Association’s Scientific Sessions 2019
|
1
|
Resverlogix Corp.
|
Sep 23, 2019 08:39AM
|
|
Re: Resverlogix Announces BETonMACE Trial Results Accepted for Presentation at American Heart Association’s Scientific Sessions 2019
|
2
|
Resverlogix Corp.
|
Sep 23, 2019 08:48AM
|
|
Re: Resverlogix Announces BETonMACE Trial Results Accepted for Presentation at American Heart Association’s Scientific Sessions 2019
|
1
|
Resverlogix Corp.
|
Sep 23, 2019 08:50AM
|
|
Re: Resverlogix Announces Change to its Board of Directors
|
6
|
Resverlogix Corp.
|
Dec 11, 2019 09:39AM
|
|
Re: Resverlogix Announces Ninth Positive DSMB Recommendation for Phase 3 Study of Apabetalone
|
1
|
Resverlogix Corp.
|
Mar 27, 2019 12:32PM
|
|
Re: Resverlogix Announces Participation at Prominent Industry and Investor Conferences
|
2
|
Resverlogix Corp.
|
Mar 11, 2019 11:15AM
|
|
Re: Resverlogix Announces Participation at Prominent Industry and Investor Conferences
|
3
|
Resverlogix Corp.
|
Mar 11, 2019 09:32AM
|
|
Re: RESVERLOGIX ANNOUNCES PROPOSED OFFERING OF UNITS April 17, 2018
|
1
|
Resverlogix Corp.
|
May 14, 2019 08:49PM
|
|
Re: RESVERLOGIX ANNOUNCES PROPOSED OFFERING OF UNITS April 17, 2018
|
1
|
Resverlogix Corp.
|
May 14, 2019 09:05PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
1
|
Resverlogix Corp.
|
Mar 30, 2020 12:10PM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
|
Resverlogix Corp.
|
Mar 30, 2020 09:20AM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
7
|
Resverlogix Corp.
|
Mar 30, 2020 09:32AM
|
|
Re: Resverlogix Announces Publication on Apabetalone in Clinical Epigenetics
|
2
|
Resverlogix Corp.
|
Jul 15, 2019 06:53PM
|
|
Re: Resverlogix Announces Topline Results in BETonMACE Phase 3 Epigenetics Trial
|
1
|
Resverlogix Corp.
|
Sep 30, 2019 07:36AM
|
|
Re: RESVERLOGIX ANNOUNCES. $15.1 MILLION OF PRIVATE PLACEMENTS
|
1
|
Resverlogix Corp.
|
Apr 01, 2019 08:58AM
|
|
Re: RESVERLOGIX ANNOUNCES. $15.1 MILLION OF PRIVATE PLACEMENTS
|
2
|
Resverlogix Corp.
|
Apr 01, 2019 09:25AM
|
